Cresset Asset Management, LLC Agenus Inc Transaction History

Cresset Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $26,310 - $38,850	-11,196 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $840 - $1,653	288 Added 2.64%	11,196 $36,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $1,767 - $2,353	355 Added 3.36%	10,908 $57,000
Q2 2021 Aug 10, 2021	BUY	$2.56 - $5.49 $27,015 - $57,935	10,553 New	10,553 $58,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.